Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Harness the power of social media for personal debt fundraising. Connect with your network and increase your chances of success.
18,294 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Investors brace for a potential 2026 stock market crash as volatility rises. Three defensive ETFs offer ballast with ...
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
March could reveal a powerful momentum move for a marquee AI stock. Learn why this genius stock that could surge on A...
Tired of watching your grocery receipts grow? This guide delivers proven cheap grocery shopping tips you can put into...
Artificial intelligence (ai) is moving from pilot projects to mission-critical software. This article examines a lead...
Guardian (GRDN) is shaping up as a data-driven growth story in 2026. This deep dive breaks down the Q1 2026 earnings ...
This week brings four major earnings reports that could reveal trends in consumer spending, AI demand, and corporate ...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
As AI hype climbs, one tech stock think more could offer substantial upside in the S&P 500. This article lays out the...
Visa and Mastercard dominate the way billions of purchases are paid for worldwide. This article explains why their ne...
For the 16th straight week, home listing prices fall across many markets as higher borrowing costs and rising invento...